Pre-Market Alert - 4 Stocks That You Should Be Watching Today (4/7/2016)
ACCESS Newswire
NEW YORK, NY / ACCESSWIRE / April 7, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. MSTX, REXX, ARTH and TRTC are on high volume alert. Continue reading to find out why these stocks are getting so much interest today. - If you want reports on the day's hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.
Mast Therapeutics, Inc. (NYSE: MSTX) Is a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The companys lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure.
The company announced that data from nonclinical studies of vepoloxamer, its lead product candidate, were presented at the American College of Cardiology 65th Annual Scientific Sessions & Expo.
Shares of MSTX have been on the rise lately, up over 40% since late March. This stock is definitely worth a second look.
Arch Therapeutics, Inc. (OTCQB: ARTH) Is a life science medical device company. The company focuses on developing products based on a novel technology to stop bleeding and control leaking during surgery and trauma care.ny in the Appalachian and Illinois basins in the United States.
Shares of ARTH have been on a hot streak since late March, making big gains almost every single day since March 20.
Keep an eye on ARTH to see if it can continue to push new highs, however, shares have an RSI (relative strength index) of 83.60, and is 20 cents over its 200 day MA (moving average) suggesting that shares are extremely oversold.
Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.
Rex Energy Corporation (NASDAQ: REXX) The company operates as an independent oil, natural gas liquid, and natural gas company in the Appalachian and Illinois basins in the United States.
The past month has been a literal roller coaster ride for Rex Energy. After a few hot days back in early-mid March, shares of REXX have since cooled off and gave back most of its recent gains.
Other than that recent burst in gains, REXX is in a downward trend and technical indicators are not showing very many good signs.
Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.
Terra Tech Corp. (OTCQX: TRTC) Terra Tech Corp. engages in the design, marketing, and sale of hydroponic equipment with proprietary technology to create sustainable solutions for the cultivation of indoor agriculture in Newport Beach and Irvine, California.
Yesterday, TRTC announced that Terra Tech's first Nevada-based medical cannabis dispensary, located at 1921 Western Avenue in Las Vegas, has had its final business license approved by the Las Vegas City Council.
The good news pushed shares of TRTC even higher, which, like ARTH, have been on a hot streak.
Unlike ARTH, however, TRTC looks like it has a better chance of holding onto these gains and going even higher, with better technicals and news to back up the recent, much steadier rise in share price.
NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.
The OTC Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.
To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word "OTCLEADER".
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The OTC Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. The OTC Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit otc-expert.com/disclaimer website for a more detailed discussion of risks and disclosures.
